Literature DB >> 7615830

Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

C M Stein1, R Nelson, R Deegan, H He, M Wood, A J Wood.   

Abstract

Impaired beta adrenoceptor-mediated vasodilation associated with enhanced sympathetic activity has been reported in established hypertension. We examined whether altered beta adrenoceptor-mediated vasodilation occurs early in the disease process, when structural vascular changes are likely to be less marked, by measurement of forearm blood flow by strain gauge plethysmography after the intraarterial administration of increasing doses of a beta receptor agonist, isoproterenol, in eight subjects with borderline hypertension (BHT) and 13 normotensive (NT) controls. To determine the role of sympathetic activation in the regulation of responsiveness, we measured local sympathetic activity in the forearm by a radioisotope dilution technique. Vasodilation in response to isoproterenol, measured either as changes in forearm blood flow or forearm vascular resistance, was impaired in the BHT group so that flow at the highest dose of isoproterenol (400 ng/min) increased less (15.2 +/- 1.5 ml/100 ml per min) than in the NT group (24.4 +/- 2.4 ml/100 ml per minute) (P < 0.001). Although, systemic norepinephrine spillover was significantly greater in BHT, the difference in blood flow response to isoproterenol was not accounted for by increased local sympathetic activity since forearm norepinephrine spillover at baseline (BHT 1.0 +/- 0.4 ng/min vs. NT 0.64 +/- 0.13 ng/min) and after the administration of isoproterenol 60 ng/min (BHT 5.2 +/- 1.4 ng/min vs. NT 6.0 +/- 1.5 ng/min) and 400 ng/min (BHT 13.5 +/- 2.9 ng/min vs. NT 16.5 +/- 2.7 ng/min) did not differ between the two groups. We therefore conclude that vasodilation in response to isoproterenol is impaired in subjects with BHT and that this impairment is not explained by locally increased basal, or stimulated, sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615830      PMCID: PMC185232          DOI: 10.1172/JCI118070

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Calcium entry blockade and adrenergic vascular reactivity in hypertensives: differences between nicardipine and diltiazem.

Authors:  R Pedrinelli; G Panarace; A Salvetti
Journal:  Clin Pharmacol Ther       Date:  1991-01       Impact factor: 6.875

2.  Body fat and sympathetic nerve activity in healthy subjects.

Authors:  U Scherrer; D Randin; L Tappy; P Vollenweider; E Jéquier; P Nicod
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

Review 3.  Microvascular function in human essential hypertension.

Authors:  A C Shore; J E Tooke
Journal:  J Hypertens       Date:  1994-07       Impact factor: 4.844

4.  Long-term exposure to beta 2-receptor agonist specifically desensitizes beta-receptor-mediated venodilation.

Authors:  M Stein; R Deegan; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1993-08       Impact factor: 6.875

5.  Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.

Authors:  D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Beta-adrenergic receptor-mediated release of norepinephrine in the human forearm.

Authors:  M Stein; R Deegan; H He; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1993-07       Impact factor: 6.875

7.  Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.

Authors:  P C Chang; E Kriek; P van Brummelen
Journal:  J Hypertens       Date:  1994-02       Impact factor: 4.844

8.  Preserved endothelium-dependent vasodilatation in patients with essential hypertension.

Authors:  J R Cockcroft; P J Chowienczyk; N Benjamin; J M Ritter
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

9.  Does regional norepinephrine spillover represent local sympathetic activity?

Authors:  P C Chang; E Kriek; J A van der Krogt; P van Brummelen
Journal:  Hypertension       Date:  1991-07       Impact factor: 10.190

10.  Vasodilation to acetylcholine in primary and secondary forms of human hypertension.

Authors:  S Taddei; A Virdis; P Mattei; A Salvetti
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

View more
  27 in total

1.  Vascular receptors as new substrates for matrix metalloproteinases in hypertension and other inflammatory states.

Authors:  Theodore J Kalogeris; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-16       Impact factor: 4.733

Review 2.  The role of cardiac autonomic function in hypertension and cardiovascular disease.

Authors:  Paolo Palatini; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

3.  Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients.

Authors:  Raffaele Izzo; Ersilia Cipolletta; Michele Ciccarelli; Alfonso Campanile; Gaetano Santulli; Gianluigi Palumbo; Antonio Vasta; Salvatore Formisano; Bruno Trimarco; Guido Iaccarino
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

4.  Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.

Authors:  Stephen F Rodrigues; Edward D Tran; Zuleica B Fortes; Geert W Schmid-Schönbein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

5.  Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults.

Authors:  LaBarron K Hill; Andrew Sherwood; Maya McNeilly; Norman B Anderson; James A Blumenthal; Alan L Hinderliter
Journal:  Psychosom Med       Date:  2018 Feb/Mar       Impact factor: 4.312

6.  Reduced arterial vasodilatation in response to hypoxia impairs cerebral and peripheral oxygen delivery in hypertensive men.

Authors:  Igor A Fernandes; Marcos P Rocha; Monique O Campos; João D Mattos; Daniel E Mansur; Helena N M Rocha; Paulo A C Terra; Vinícius P Garcia; Natália G Rocha; Niels H Secher; Antonio C L Nóbrega
Journal:  J Physiol       Date:  2018-02-28       Impact factor: 5.182

7.  Nitric oxide synthase and cyclooxygenase modulate β-adrenergic cutaneous vasodilatation and sweating in young men.

Authors:  Naoto Fujii; Brendan D McNeely; Glen P Kenny
Journal:  J Physiol       Date:  2016-12-12       Impact factor: 5.182

8.  Haemodynamic responses to salbutamol and isometric exercise are altered in young adults with mild asthma.

Authors:  W Stephen Waring; Rachel B Leigh
Journal:  Eur J Clin Pharmacol       Date:  2005-01-27       Impact factor: 2.953

9.  Increased plasma norepinephrine levels in previously pre-eclamptic women.

Authors:  K H Lampinen; M Rönnback; P-H Groop; M G Nicholls; T G Yandle; R J Kaaja
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

Review 10.  G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms.

Authors:  Gaetano Santulli; Bruno Trimarco; Guido Iaccarino
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.